Live from the NIH registry
Studies recruiting near Savannah right now
Top 25 of 174 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
St. Joseph — Savannah, Georgia (6.1 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Summit Cancer Care, PC — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Septic Shock, Sepsis
Phase 3
Interventional 46 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Vivacelle Bio
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: Eli Lilly and Company
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Eastern Cooperative Oncology Group
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 160 participants sought
Atd002 52015 — Savannah, Georgia (6.1 mi)
· Sponsor: UCB Biopharma SRL
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
CenExel iRS (iResearch Savannah) — Savannah, Georgia (6.1 mi)
· Sponsor: Syndeio Biosciences, Inc
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
iResearch Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Charleston Neuroscience Institute - Bluffton (Site 124) — Bluffton, South Carolina (23.7 mi)
· Sponsor: EyeBiotech Ltd.
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Nancy N and JC Lewis Cancer & Research Pavilion St. Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Georgia Skin & Cancer Clinic — Savannah, Georgia (6.1 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Southeast Lung Associates Research — Rincon, Georgia (18.7 mi)
· Sponsor: Harmony Biosciences Management, Inc.
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Treatment-resistant Depression (TRD)
Phase 2
Interventional 178 participants sought
Site 7141 — Savannah, Georgia (6.1 mi)
· Sponsor: Alto Neuroscience
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0236 - Memorial Health — Savannah, Georgia (6.1 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Phase 3
Interventional 640 participants sought
Meridian Clinical Research, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Ovarian Cancer
Phase 3
Interventional 582 participants sought
Nancy N. & J.C Lewis Cancer & Research Pavillion- St. Josephs/ Candler Health System — Savannah, Georgia (6.1 mi)
· Sponsor: Daiichi Sankyo